Consumption of coffee associated with reduced risk of liver cancer: A meta-analysis

BMC Gastroenterology

Volumn 13, Issue 1, 2013, Pages

  Sang, Li Xuan ^a   Chang, Bing ^a   Li, Xiao Hang ^a   Jiang, Min ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Coffee; Epidemiology; Liver cancer; Meta analysis

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CASE CONTROL STUDY; COFFEE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; ETHNICITY; FEMALE; FOOD INTAKE; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUALITY CONTROL; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SYSTEMATIC ERROR;

CASE-CONTROL STUDIES; COFFEE; COHORT STUDIES; CONFIDENCE INTERVALS; DRINKING BEHAVIOR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; ODDS RATIO; RISK FACTORS;

EID: 84874174787     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-34     Document Type: Article

References (40)

1. Ferlay J, Bray F, Pisani P. GLOBOCAN 2002: Cancer Incidence, Mortality, and Prevalence Worldwide, IARC CancerBase No. 5. version 2.0. Lyon, France: International Agency for Cancer Research 2004,
2. Stewart BW, Kleihues P. World cancer report 2003, Lyon: IARC Press: Stewart BW, Kleihues P.
3. Srivatanakul P, Spriplung H, Deerasamee S. Epidemiology of liver cancer: an overview. Asian Pacific J Cancer Prev 2004, 5:118-125.
4. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917. 10.1016/S0140-6736(03)14964-1, 14667750.
5. Franceschi S, Montella M, Polesel J. Hepatitis viruses, alcohol and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev 2006, 15:683-689. 10.1158/1055-9965.EPI-05-0702, 16614109.
6. Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004, 127(Suppl 1):S72-S78.
7. Kiyosawa K, Umemura T, Ichijo T. Hepatocellular carcinoma: Recent trends in Japan. Gastroenterology 2004, 127(suppl 1):S17-S26.
8. Aizawa Y, Shibamoto Y, Takagi I. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C.A long term follow-up study after histologic diagnosis. Cancer 2000, 89:53-59. 10.1002/1097-0142(20000701)89:1<53::AID-CNCR8>3.0.CO;2-6, 10897000.
9. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987, 9:1-30.
10. Wells GA, Shea B, O'Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in the meta-analysis Available from; 2011. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp(cited 19 March 2011).
11. Kuper H, Tzonou A, Kaklamani E. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000, 85:498-502. 10.1002/(SICI)1097-0215(20000215)85:4<498::AID-IJC9>3.0.CO;2-F, 10699921.
12. Gallus S, Bertuzzi M, Tavani A. Does coffee protect against hepatocellular carcinoma?. Br J Cancer 2002, 87:956-959. 10.1038/sj.bjc.6600582, 2364316, 12434283.
13. Gelatti U, Covolo L, Franceschini M. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 2005, 42:528-534. 10.1016/j.jhep.2004.11.039, 15868652.
14. Ohfuji S, Fukushima W, Tanaka T. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study. Hepatol Res 2006, 36:201-208. 10.1016/j.hepres.2006.07.010, 16916617.
15. Tanaka K, Hara M, Sakamoto T. Inverse association between coffee drinking and the risk of hepatocellular carcinoma:a case-control study in Japan. Cancer Sci 2007, 98:214-218. 10.1111/j.1349-7006.2006.00368.x, 17233838.
16. Montella M, Polesel J, La Vecchia C. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 2007, 120:1555-1559. 10.1002/ijc.22509, 17205531.
17. Wakai K, Kurozawa Y, Shibata A. Liver cancer risk, coffee, and hepatitis C virus infection: a nested case-control study in Japan. Br J Cancer 2007, 97:426-428. 10.1038/sj.bjc.6603891, 2360330, 17637681.
18. Ohishi W, Fujiwara S, Cologne JB. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2008, 17:846-854. 10.1158/1055-9965.EPI-07-2806, 18398026.
19. Leung WW, Ho SC, Chan HL. Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case- control study. J Epidemiol Community Health 2011, 65:556-558. 10.1136/jech.2009.104125, 20693491.
20. Shimazu T, Tsubono Y, Kuriyama S. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005, 116:150-154. 10.1002/ijc.20989, 15756689.
21. Inoue M, Yoshimi I, Sobue T. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005, 97:293-300. 10.1093/jnci/dji040, 15713964.
22. Kurozawa Y, Ogimoto I, Shibata A. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005, 93:607-610. 10.1038/sj.bjc.6602737, 2361599, 16091758.
23. Hu G, Tuomilehto J, Pukkala E. Joint effects of coffee consumption and serum gam-ma-glutamyltransferase on the risk of liver cancer. Hepatology 2008, 48:129-136. 10.1002/hep.22320, 18537182.
24. Inoue M, Kurahashi N, Iwasaki M. Effect of coffee and green tea consumption on the risk of liver cancer:cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 2009, 18:1746-1753. 10.1158/1055-9965.EPI-08-0923, 19505908.
25. Johnson S, Koh WP, Wang R. Coffee consumption and reduced risk of hepatocellular carcinoma:findings from the Singapore Chinese Health Study. Cancer Causes Control 2011, 22:503-510. 10.1007/s10552-010-9725-0, 3400401, 21258859.
26. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558. 10.1002/sim.1186, 12111919.
27. Hedges LV, Pigott TD. The power of statistical tests in meta-analysis. Psychol Methods 2001, 6:203-217.
28. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101. 10.2307/2533446, 7786990.
29. Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998, 316:61-66. 10.1136/bmj.316.7124.61, 2665334, 9451274.
30. Bravi F, Bosetti C, Tavani A. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007, 46:430-435. 10.1002/hep.21708, 17580359.
31. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a meta- analysis. Gastroenterology 2007, 132:1740-1745. 10.1053/j.gastro.2007.03.044, 17484871.
32. Asaad NA, Zeng ZC, Guan J. Homologousre combination as a potential Target for caffeine radiosensitization in mammalian cells: reduced caffeine radio sensitizationin XRCC2 and XRCC3 mutants. Oncogene 2000, 19:5788-5800. 10.1038/sj.onc.1203953, 11126366.
33. Saiki S, Sasazawa Y, Imamichi Y. Caffeine induces apoptosis by enhancemen t of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy 2011, 7:176-187. 10.4161/auto.7.2.14074, 3039768, 21081844.
34. Joerges C, Kuntze I, Herzinger T. Induction of a caffeine-sensitive S-phase cell cycle checkpoint by psoralen plus ultraviolet A radiation. Oncogene 2003, 22:6119-6128. 10.1038/sj.onc.1206613, 13679850.
35. Azam S, Hadi N, Khan NU. Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. Med Sci Monit 2003, 9:BR325-BR330.
36. Hosaka S, Kawa S, Aoki Y. Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene. Food Chem Toxicol 2001, 39:557-561. 10.1016/S0278-6915(00)00175-7, 11346485.
37. Cavin C, Holzhaeuser D, Scharf G. Cafestol and kahweol, two coffee specific diterpenes with anticarcino-Genic activity. Food Chem Toxicol 2002, 40:1155-1163. 10.1016/S0278-6915(02)00029-7, 12067578.
38. Majer BJ, Hofer E, Cavin C. Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine(PhIP)and N-nitro- Sodimethylamine in a human derived liver cell line(HepG2). Food Chem Toxicol 2005, 43:433-441. 10.1016/j.fct.2004.11.009, 15680679.
39. Cavin C, Holzhauser D, Constable A. The coffee-specific diterpenes cafestol and kahweol protect against afla-toxinB1-induced genotoxicity through a dual mechanism. Carcinogenesis 1998, 19:75-1369.
40. Feng R, Lu Y, Bowman LL. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 2005, 280:27888-27895. 10.1074/jbc.M503347200, 15944151.